{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:51:42Z","timestamp":1790887902640,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cmi.2021.05.048","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T23:49:30Z","timestamp":1623109770000},"page":"248-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study"],"prefix":"10.1016","volume":"28","author":[{"given":"Thijs","family":"ten Doesschate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis Henri","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien C.","family":"van der Hout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara N.","family":"Platteel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene A.M.","family":"Groenewegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk E.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy I.M.","family":"Hoepelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Geerlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2021.05.048_bib1","series-title":"NHG standaard: urineweginfecties","author":"Bouma","year":"2020"},{"key":"10.1016\/j.cmi.2021.05.048_bib2","series-title":"Urinary tract infection (recurrent): antimicrobial prescribing. Draft for consultation","year":"2018"},{"key":"10.1016\/j.cmi.2021.05.048_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2018.4204","article-title":"Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections: a randomized clinical trial","author":"Hooton","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2021.05.048_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cmi.2016.12.006","article-title":"\u2018Old\u2019 is not always bad","volume":"23","author":"Verheij","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.05.048_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pathogens5020036","article-title":"Non-Antibiotic prophylaxis for urinary tract infections","volume":"5","author":"Beerepoot","year":"2016","journal-title":"Pathogens"},{"key":"10.1016\/j.cmi.2021.05.048_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.idc.2013.10.001","article-title":"Prevention of recurrent urinary tract infections in women. Antimicrobial and nonantimicrobial strategies","author":"Geerlings","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.cmi.2021.05.048_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2017.12.026","article-title":"Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study","author":"Stewardson","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.05.048_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmi.2016.08.003","article-title":"Nitrofurantoin\u2019s efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials","volume":"23","author":"Muller","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.05.048_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ajog.2016.07.040","article-title":"Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis","volume":"215","author":"Price","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cmi.2021.05.048_bib10","series-title":"NethMap 2019: consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands\/MARAN 2019: monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2018","first-page":"251","author":"de Greef","year":"2019"},{"key":"10.1016\/j.cmi.2021.05.048_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30279-2","article-title":"Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial","author":"Fisher","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2021.05.048_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1378\/chest.96.3.512","article-title":"Hospitalizations for pulmonary reactions following nitrofurantoin use","volume":"96","author":"Jick","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2021.05.048_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.14796","article-title":"How common are pulmonary and hepatic adverse effects in older adults prescribed nitrofurantoin?","author":"Claussen","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.cmi.2021.05.048_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5489\/cuaj.687","article-title":"Guidelines for the diagnosis and management of recurrent urinary tract infection in women","volume":"5","author":"Dason","year":"2011","journal-title":"J\u00a0Can Urol Assoc"},{"key":"10.1016\/j.cmi.2021.05.048_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1186\/s12913-018-3528-5","article-title":"Routine primary care data for scientific research, quality of care programs and educational purposes: the Julius General Practitioners\u2019 Network (JGPN)","volume":"18","author":"Smeets","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cmi.2021.05.048_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkz095","article-title":"The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover study","author":"Huttner","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2021.05.048_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-213967","article-title":"Nitrofurantoin-induced interstitial pneumonitis: albeit rare, should not be missed","volume":"2016","author":"Syed","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cmi.2021.05.048_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9343(80)90443-X","article-title":"Adverse reactions to nitrofurantoin: analysis of 921 reports","author":"Holmberg","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2021.05.048_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/42.3.363","article-title":"Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years\u2019 experience","author":"Brumfitt","year":"1998","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2021.05.048_bib22","doi-asserted-by":"crossref","first-page":"e830","DOI":"10.3399\/bjgp17X693641","article-title":"Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study","volume":"67","author":"Butler","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2021.05.048_bib23","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.3399\/bjgp17X689641","article-title":"Antibiotic prescribing during office hours and out-of-hours: a comparison of quality and quantity in primary care in the Netherlands","volume":"67","author":"Debets","year":"2017","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2021.05.048_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-410X.2008.08008.x","article-title":"The risks of long-term nitrofurantoin prophylaxis in patients with recurrent urinary tract infection: a recent medico-legal case","author":"Cetti","year":"2009","journal-title":"BJU Int"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21002998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21002998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:32:07Z","timestamp":1761118327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X21002998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1198743X21002998"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2021.05.048","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2021.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}